This live virtual session with Dr. Megha Poddar, MD, FRCPC, DABOM took place on Tuesday, September 22, 2026, as part of the accredited 2026 Primary Care Expert Series.
When and where
Date: Tuesday, September 22, 2026
Time: 8:00 to 9:30 PM ET
Location: Live online
Learning objectives
By the end of this session, you’ll be able to:
Apply a structured approach to obesity assessment in primary care, including staging, comorbidity screening, and identifying who benefits most from medication.
Select and sequence anti-obesity pharmacotherapy using an evidence-based approach, including GLP-1 receptor agonists and dual incretin agents, with practical guidance on dosing, titration, and expected response.
Manage follow-up safely and effectively, including monitoring parameters, side effects, stopping rules, weight regain prevention, and when to co-manage or refer.
About the speaker
Dr. Megha Poddar is an endocrinologist and obesity medicine specialist. She serves as Medical Director of the Medical Weight Management Centre of Canada and is an author of the Canadian Adult Obesity Clinical Practice Guidelines. She has published extensively in obesity management and holds an academic appointment as an Assistant Clinical Professor in the Department of Internal Medicine at McMaster University. Her clinical work focuses on evidence-based obesity treatment, including pharmacotherapy and long-term weight management.
This series is supported by educational grants from L’Oréal Canada, Duchesnay, Organon and Lupin.
Watch on demand
Missed this session? Registration includes every replay, fully accredited for ANCC contact hours.